Search

The REPhRAME project, coordinated by Universitätsmedizin Frankfurt under Prof. Maria J.G.T. Vehreschild, has been awarded €15 million through Horizon Europe; it began in June 2026 and is planned to run for five years. It will assess in a ra

Non-peer-reviewed scoping-review poster from the NSU KPCOM Student Research Day (May 15, 2026), published on Cureus, that searched six databases for studies of bacteriophage therapy in autoimmune disease. It reports disease-associated chang

Precise Health SA, a Biopôle-based EPFL spin-out, has kicked off an Innosuisse Innovation Project worth approximately CHF 900,000 with the University of Geneva and Geneva University Hospitals (HUG). The project builds on its AI-powered Phag

Gladstone launched the Center for PhAIge Therapy to harness AI for research on drug-resistant infections. NIAID provided an initial $2 million award, with total funding up to $10 million available over the proposed five-year project period.

Intralytix announced a multimillion-dollar NIH P01 award for a Pitt-led CAPT-CEP project developing phage therapy for multidrug-resistant Pseudomonas aeruginosa. The collaboration includes Pitt, Walter Reed, USC, Florida International Unive

NIAID awarded three CAPT-CEP centers to build preclinical tools, assays and models for phage therapy against ESKAPE pathogens. The FY 2026 program provides $6 million across three awards, each up to $1.2 million in annual direct costs for u

Phage Consultants (Marcin Łoś, Gdynia, Poland) is developing PhageSense, a platform for rapid, sensitive and repeatable detection of bacteriophage infections in bacterial cultures and industrial fermentation samples that combines fluorescen

EcoPhage signed an evaluation and pre-commercialization agreement with Dole Fresh Fruit International to apply its technology against bacterial plant diseases in bananas, including Moko disease caused by Ralstonia solanacearum. EcoPhage

Phage Foundry lists PI Vivek Mutalik as A-LIFT’s 2026 Outstanding Mentor of the Year. phagefoundry.org

Lytic Selection and Evolution (LySE) uses a modified bacteriophage to evolve long gene clusters. In a proof of concept, the team improved bacterial degradation of a plastic ingredient by more than 50% after five cycles. National University

Cytophage announced that Will Ollerhead resigned as a director effective April 29, 2026. Cytophage Technologies Ltd.

Tristan Ferry discusses PHAGEinLYON’s clinical experience with compassionate use and clinical trials in a talk hosted on Canal-U. Phages.fr on Canal-U

Researchers, students and professionals from multiple institutions took part in phage research training through a collaboration between TU-K and the Phage Hunters Training and Research Program. The programme combined online theory with hand

Cytophage announced that Chief Operating Officer Heather Medwick left the company effective March 31, 2026, as part of its corporate restructuring. Cytophage Technologies Ltd.

The University at Buffalo reports clearance of a patient’s chronic MRSA infection following phage therapy alongside antibiotics and hip hardware replacement. Patrick Kenney’s team developed the patient-specific phage after years of recurren

McMaster University researchers report in mBio (published March 30, 2026) that Pseudomonas aeruginosa can evade phage attack by entering a temporary "stealth mode". Of 28 phage-resistant mutants studied, one regained full pili function in a

Avir Mitra explores antibiotic resistance in this Radiolab live-show episode. The episode page also links to a bacteriophage deep dive with Mitra and Steffanie Strathdee, plus a recording of the live show and bonus Q&A. Radiolab

An ODIN-funded collaborative project led by Professor Hanne Ingmer (University of Copenhagen) brings academic and industry partners together to develop next-generation tools for phage-based therapies against chronic wound and urinary tract

The ANR-supported PHAG-ONE project, led by Prof. Frédéric Laurent (Hospices Civils de Lyon), is creating a national public infrastructure for GMP-grade production of therapeutic phages. The platform has produced three GMP pilot batches of f

The 2026 SEA-PHAGES genome announcement workflow supports one microPublication Biology announcement per SEA school, with a reduced $150 publication fee. Participating schools’ final manuscript submission deadline is December 31, 2026. SEA-P